Chapter 192: To ban

"Seattle Times": Pangu Technology ’s clinical trials are a serious violation of medical regulations. It took less than half a year from the emergence of their technology to the final clinical treatment, which not only violated the international clinical trial rules for the treatment of malignant tumors, but also violated Xia Guo's own rules for clinical experiments. We have reason to suspect that Pangu Technology ’s clinical trials are simply a procedure, and we have reason to suspect that Pangu Technology ’s technology came from the United States.
"New York Times": The New York court accepted Bristol-Myers Squibb's infringement on Pangu Technology's gene expression therapy infringement case. Bristol-Myers Squibb has provided sufficient evidence. If Pangu Technology should not sue, the court will abstain from trial. In addition, Bristol-Myers Squibb also appealed the case to more than 20 international intellectual property organizations, and asked Xiaguo's relevant departments to address Squibb's claims squarely and stop the treatment of Pangu Technology's related technologies.
After the New York Times came out, many Western media rushed to report.
Many well-known medical institutes, including Stanford University's Institute of Molecular Medicine, Mayo Clinic, Moffitt Cancer Center and Institute, have followed the progress of the matter.
They expressed doubts after the Pangu Science and Technology Paper came out, and they even doubted the authenticity of the Gene Expression paper published in the Cell journal.
At the same time, the FDA of the country also officially issued a notice of investigation to Pangu Technology. The reason for FDA's doubts about Pangu Technology is that the physical indicators of patients in Pangu Science and Technology before and after treatment, and the treatment methods are similar to those of nivolumab after treatment. .
Gao Siqi came to Xiao Ming's office with the FDA's investigation notice and said, "The rice people are going crazy!"
Qian Yi, who was talking to Xiao Ming, looked at the survey notice and said, "What are they thinking? Pangu Technology does not have any business in the rice country. A department in the rice country can investigate Xia's company?"
Gao Siqi said, "Squibb's nivolumab has been banned worldwide, and the FDA has asked us to stop suppressing gene therapy."
Qian Yi asked a little strangely: "Nabuzumab stopped selling globally? Isn't Squibb a serious loss?"
Xiao Ming knew what Gao Siqi wanted to say. "The investigation initiated by the FDA and more than 20 intellectual property organizations around the world should not only be a separate act of Bristol-Myers Squibb, but the behavior of the entire medical profession in the country. The sale of navumab shortly after the listing in exchange for Xia Guo lost a treatment that changed the global medical industry. This sale is quite cost-effective! "
Gao Siqi also added: "Now I fully understand the calculations of Miguo. Bristol-Myers Squibb has many cancer-targeting drugs. Even if nivolumab is no longer sold, there are still many alternative cancer-targeting drugs, and their profits are There is almost no loss. The loss is just the patient's chance of survival. Those cancer patients will buy other drugs from Squibb even if they cannot buy nivolumab, but what Pangu Technology and the whole China have lost is to inhibit the development of gene therapy. opportunity."
Qian Yi asked: "These pharmaceutical companies and medical departments in China are so bloody? Do they care about the survival chances of patients?"
Xiao Ming laughed: "Bloody? Which pharmaceutical company does not rely on blood to make a fortune? Cancer in the United States has only life expectancy, and there is no 100% successful treatment. As long as the benefits are not damaged, early death and late death do not seem to these pharmaceutical companies. What a difference. "
Gao Siqi said: "According to the agreements of multiple intellectual property organizations, the relevant departments of Xia Guo should respond to them. Anyway, we of Pangu Technology will not respond. Anyway, I am afraid that we will not speak with rice. clear."
"The news is here," Qian Yi said, brushing her phone.
On Weibo, Xia Guo's media have spoken to the FDA notice. In addition to sternly refuting it, there are also accusations that the law of the State of Mi cannot govern Xia Guo's enterprises.
Qian Yi handed the phone to Xiao Ming.
In addition to Xia Guo media's refutation of the FDA notice, many netizens are also speaking out for Pangu Technology.
"The Ricelanders are so disgusting! How to use the Riceland laws to demand Xia's company."
"None of us is using the operating system in the country. Why are we still saying that we infringe intellectual property?"
"Just can't see us, okay?"
"It must be said that we infringe intellectual property rights! Targeted medicines imported will be tens of thousands of dollars a month, and our technology will be fully cured after three or four hundred thousand. Is there any way for these Miguo pharmaceutical companies to survive?"
The Affiliated Hospital of Jiangcheng University also spoke for Pangu Technology. In the announcement of the affiliated hospital, more than ten oncologists said: "Suppression of gene expression therapy. Pangu Technology has independent intellectual property rights and is a new generation of nauseous tumors advanced than targeted therapy. Therapy. Jiangcheng University will not stop using this technology to treat patients. "
After reading the news, Xiao Ming said, "Pangu Technology will be settled by Pangu Technology itself ~ EbookFREE.me ~ We also have to learn to deal with Westerners from this incident."
Xiao Ming arranged a task for Gao Siqi and said, "Do nothing and proceed according to plan. We have no business in the country and we will not be afraid of any investigations and trials. Also, if Xia country really accepts the conditions of the country, it is forbidden to suppress gene therapy. Used in the Xia Guo medical field, then I think Pangu Group can also move. "
What Xiao Ming said is very serious. This incident is a test for Pangu Technology and a test of Xia Guo's technical confidence.
However, with Xiao Ming's instructions, Gao Siqi was able to carry out her work more boldly.
The first is to increase the capacity of inhibitors, and the second is to cooperate with the affiliated hospital of Jiangcheng University to expand the treatment of patients.
Xiao Ming also agreed with Jiangda Affiliated Hospital. After Jiangda Affiliated Hospital is full, patients will spread out with Jiangda Affiliated Hospital as the center, and send technical staff to other top three hospitals, so that patients from all over the country will be at their doorstep. Can be treated.
The Affiliated Hospital of Jiangcheng University also stated that it will actively communicate with higher authorities to fight against the implementation of the technical ban.
Many patients are very panic after seeing reports from foreign media and various news on the Internet. What if patients are really prohibited from suppressing gene expression therapy?
Many people leave a message under Pangu Technology asking for the latest news.
"Why do Chinese people manage our patients in Xia Kingdom!"
"Don't forbid! I just registered for my father!"
"If joining the International Intellectual Property Organization has such an impact on the Summer Congress, why should we join?"
For the patients' questions, Pangu Technology responded in unison: "We will not give up any one patient."
https: //
Genius remember the address of this site in a second :. Mobile website reading URL: